$DXCM · DEXCOM INC SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for DEXCOM INC ($DXCM) from October 29, 2026 through October 29, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$DXCM 10-Q — DEXCOM INC
The divergence between surging operating performance (+35% operating income) and declining net income (-3%) reveals how non-recurring investment gains masked prior-year results,…
$DXCM 8-K — DEXCOM INC
Dexcom delivered a rare triple: an earnings beat, a guidance raise across multiple metrics, and a $1B buyback — signaling management confidence in the G7 15 Day product cycle.